Adawi Kamal (CIK 1788393) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-16). Recent activity: Buy FATE (25,000 shares), Buy FATE (75,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-16 | FATE THERAPEUTICS INC (FATE) | Chief Financial Officer | Buy | 25,000 | $0 |
| 2025-10-21 | FATE THERAPEUTICS INC (FATE) | Chief Financial Officer | Buy | 75,000 | $0 |
Source: SEC Form 4 filings · as of 2026-01-16